Curated · Healthcare

Big pharma

By InspectStocksPublished Oct 14, 202613 companies0 followers

The largest drugmakers, selling prescription medicines worldwide.

Grouped with the help of an AI model and reviewed by our editors. The line under each company says why it is here.

Download image

Cards Tiers

Share prices are the Nov 11, 2026 close, from the IEX exchange feed.

Grade mix

A 7B 3C 3

Revenue growing

12 of 12

Free cash flow growing

9 of 13

Median price move, 1 year

+34.0%

Sort by

LLYELI LILLY AND COMPANY
Drug manufacturers generalMarket cap $1.35TP/E 46.67
$1,437.79+42.2%1Y
Since added +23.2%
A+
Growth & cash
Growing strongly
Business trend
Steady
Business quality
Strong
Getting better
Improving
Revenue
$86.5B+45.5%
Profit
$27.6B+49.8%
Free cash flow
$19.7B+112.1%
Discuss
Why it is here: Sells prescription medicines for diabetes, obesity, cancer and inflammation
JNJJohnson & Johnson
Drug manufacturers generalMarket cap $674.9BP/E 42.54
$280.34+47.5%1Y
Since added +12.8%
A+
Growth & cash
Growing strongly
Business trend
Steady
Business quality
Strong
Getting better
Mixed
Revenue
$99.3B+7.8%
Profit
$16.1B-35.9%
Free cash flow
$20.6B+5.1%
Discuss
Why it is here: Sells prescription medicines for cancer and immune disorders
ABBVAbbVie Inc.
Drug manufacturers generalMarket cap $521.2BP/E 50.75
$294.87+30.2%1Y
Since added +7.5%
B+
Growth & cash
Growing strongly
Business trend
Steady
Business quality
Strong
Getting better
Improving
Revenue
$66B+10.7%
Profit
$10.3B+333.1%
Free cash flow
$18.9B-4.1%
Discuss
Why it is here: Sells medicines for immune, neurological and cancer conditions
MRKMerck & Co., Inc.
Drug manufacturers generalMarket cap $362.9BP/E 150.20
$147.20+65.7%1Y
Since added +3.7%
A
Growth & cash
Growing strongly
Business trend
Steady
Business quality
Solid
Getting better
Mixed
Revenue
$67.4B+4.9%
Profit
$2.5B-87.1%
Free cash flow
$14.7B+13.0%
Discuss
Why it is here: Sells prescription medicines and vaccines for people and animals
NVSNovartis AG
Drug manufacturers generalMarket cap $306BNo P/E (operating loss)
$160.36+23.6%1Y
Since added +12.6%
A
Growth & cash
Growing strongly
Business quality
Mixed
Getting better
Improving strongly
Revenue
$56.7B+9.6%
Profit
-$46MNo comparable year
Free cash flow
$17.6B+8.3%
Discuss
Why it is here: Sells prescription medicines
AZNASTRAZENECA PLC
Drug manufacturers generalMarket cap $289.7BP/E 28.36
$185.49+115.2%1Y
Since added +19.0%
B+
Growth & cash
Growing strongly
Business trend
Slowing
Business quality
Strong
Getting better
Improving strongly
Revenue
$62.4B+7.3%
Profit
$10.2B+45.3%
Free cash flow
$11.8B+18.4%
Discuss
Why it is here: Sells prescription medicines
NVONOVO NORDISK A/S
Drug manufacturers generalMarket cap $182.8BP/E 11.84
$41.10-15.4%1Y
Since added +8.0%
C+
Growth & cash
Growing
Business trend
Accelerating
Business quality
Strong
Getting better
Improving
Revenue
$50.3B+5.7%
Profit
$17.1B+9.1%
Free cash flow
$8.9B-20.1%
Discuss
Why it is here: Sells diabetes and obesity medicines
PFEPFIZER INC
Drug manufacturers generalMarket cap $167.9BP/E 42.07
$29.45+21.4%1Y
Since added +3.8%
C
Growth & cash
Growing strongly
Business trend
Contracting
Business quality
Solid
Getting better
Mixed
Revenue
$63.6B+1.3%
Profit
$4B-59.0%
Free cash flow
$11.8B+13.6%
Discuss
Why it is here: Sells prescription medicines and vaccines
BMYBRISTOL-MYERS SQUIBB COMPANY
Drug manufacturers generalMarket cap $128.6BP/E 13.95
$62.92+34.0%1Y
Since added +11.0%
C+
Growth & cash
Growing
Business trend
Steady
Business quality
Strong
Getting better
Improving strongly
Revenue
$50B+4.2%
Profit
$9.2B+53.1%
Free cash flow
$9.3B-39.3%
Discuss
Why it is here: Sells prescription medicines for cancer and immune conditions
SNYSanofi
Drug manufacturers generalMarket cap $59.1BP/E 6.81
$48.43-3.0%1Y
Since added +23.9%
B
Growth & cash
Growing strongly
Business trend
Steady
Business quality
Mixed
Getting better
Improving
Revenue
$53.5B+11.6%
Profit
$4.7B-54.2%
Free cash flow
$8.1B+22.5%
Discuss
Why it is here: Sells prescription medicines and vaccines
GSKGSK plc
Drug manufacturers generalMarket cap $109.2BP/E 13.60
$50.60+8.9%1Y
Since added +9.3%
A+
Growth & cash
Growing strongly
Business quality
Strong
Getting better
Improving strongly
Revenue
$43.8B+4.1%
Profit
$7.7B+122.0%
Free cash flow
$8.6B+24.0%
Discuss
Why it is here: Sells prescription medicines and vaccines worldwide
AMGNAmgen Inc.
Drug manufacturers generalMarket cap $253.2BP/E 27.14
$468.13+43.1%1Y
Since added +13.4%
A+
Growth & cash
Growing strongly
Business trend
Steady
Business quality
Strong
Getting better
Improving
Revenue
$38.9B+8.2%
Profit
$9.4B+34.1%
Free cash flow
$9.6B-17.0%
Discuss
Why it is here: Develops and sells medicines and biosimilars for serious diseases
TAKTakeda Pharmaceutical Company Limited
Drug manufacturers specialty and genericMarket cap $33.5BP/E 48.79
$20.86+50.1%1Y
Since added +12.5%
A
Growth & cash
Growing strongly
Business quality
Mixed
Getting better
Mixed
Revenue
$29.8BNo comparable year
Profit
$259.4MNo comparable year
Free cash flow
$5.5B+1.1%
Discuss
Why it is here: Sells prescription medicines and vaccines globally

Green and red compare each figure with the same window a year earlier. Grades and checks are the company page's own; nothing here is a recommendation.

DiscussionNo comments yet

Be civil and stick to the companies. Comments are opinions, not advice.

Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.